Fungiway CL Vaginal Capsule contains a combination of Clindamycin (100mg) and Clotrimazole (200mg), designed for the effective treatment of mixed vaginal infections caused by susceptible bacteria and fungi. Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis, targeting anaerobic bacteria commonly involved in bacterial vaginosis and other vaginal infections. Clotrimazole is an imidazole antifungal agent that disrupts the fungal cell membrane by inhibiting ergosterol synthesis, effectively treating candidal infections such as vulvovaginal candidiasis. The dual-action formulation provides broad-spectrum antimicrobial coverage, making it suitable for cases where both bacterial and fungal pathogens are present or suspected. Fungiway CL Vaginal Capsule is typically administered intravaginally once daily for a prescribed duration, ensuring localized drug delivery with minimal systemic absorption, thereby reducing the risk of systemic side effects. Patients should follow the full course of treatment even if symptoms improve earlier to prevent recurrence. Common side effects may include local irritation, burning sensation, or itching. It is important to consult a healthcare professional before use, especially in pregnancy or if allergic to clindamycin, clotrimazole, or related compounds. Avoid concurrent use with other intravaginal products unless advised by a physician.